281 filings
Page 4 of 15
8-K
j8wbco3d56iy2i4umon
23 Jan 18
Innovus Pharma Signs Exclusive License and Distribution Agreement
12:00am
8-K
c54spb3dpmezlmj9j
8 Jan 18
Innovus Pharma Enters Into License and Distribution Agreement with Acerus Pharmaceuticals for the Commercialization of UriVarx® in Canada
12:00am
8-K
0fmh bumlkf1
14 Nov 17
Product Currently Expected to Generate $10-$15m in Additional Revenues Annually
12:00am
8-K
6wl5656b
14 Nov 17
Innovus Pharmaceuticals Reports Nine Month Net Revenue of $6.4 million
12:00am
8-K
4z6k2
27 Sep 17
Innovus Pharma Announces the Availability of the Full Label
12:00am
8-K
w01rqj7s93c4bw6yd
31 Aug 17
Regulation FD Disclosure
12:00am
8-K
i4aggwq76hthxay
14 Aug 17
Innovus Pharmaceuticals Reports a Quarterly Net Revenue
12:00am
D
ylq3zm653j5nsg0095ba
2 Aug 17
$145.2K in equity, sold $145.2K, 1 investor
12:00am
8-K
uicx12b8m4m2hyf
20 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
ld58ru
19 Jun 17
Regulation FD Disclosure
12:00am
8-K
rcd6uwfkxt822mjfnzp
22 May 17
Innovus Pharma Signs Exclusive License and Distribution Agreement
12:00am
8-K
z9o0xeoa
16 May 17
Innovus Pharma Signs Exclusive License and Distribution Agreement
12:00am
8-K
5a7c5ea
12 May 17
Innovus Pharmaceuticals Reports Quarterly Revenue
12:00am
8-K
7bjpuw
9 May 17
Under FDA Approved ANDA No. 207957
12:00am
8-K
nzb lorzzd
14 Apr 17
Departure of Directors or Certain Officers
12:00am
S-8
ujrpnml
12 Apr 17
Registration of securities for employees
12:00am